Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-02-11 @ 4:11 AM
Study NCT ID:
NCT05337267
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2022-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Sintilimab in Healthy Chinese Male Subjects
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Male Subjects | View |
Keywords: